Skip to main content
padlock icon - secure page this page is secure

Vascular Wall-Related Biomarkers in Sepsis: A Review of Current Evidence and a Critical Appraisal of Recent Patents

Buy Article:

$63.00 + tax (Refund Policy)

Sepsis is a leading cause of death in both developed and developing world that still represents one of the major challenges to biomedical research. Treatment of sepsis is largely based on antibiotics and supportive measures, so that early diagnosis of sepsis and of its end-organ complications, could potentially improve clinical outcomes. In the last two decades, there has been intensive research activity in the field of biomarker for sepsis. However, despite a few interesting positive results, incorporation of these tools into clinical practice has been slow, maybe due to limitations in their clinical impact in “real-life” patient care. In the last years, the concept of the endothelium as the most important target organ in sepsis gained momentum, leading to the search for new vascular wall-related biomarkers in sepsis. Promising results have been published in the last years, along with very recent patent filing activity. Here, we briefly review the rationale and available data on the use of vascular wall-related biomakers in sepsis. In addition, we discuss the trends in research & development activity in this area, by presenting a selected number of patents filed in the last 10 years to the area of vascularwall biomarkers in sepsis pointing areas for commercial development.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Angiopoietin; VEGF; Vascular-wall related biomarkers; endothelium; microvascular permeability; patents; sFlt-1; sepsis; vascular-wall

Document Type: Research Article

Publication date: May 1, 2012

More about this publication?
  • Recent Patents on Biomarkers publishes review and research articles, and guest edited thematic issues on important recent patents on biomarkers. The coverage includes novel biomarkers in basic, medical, environmental, and pharmaceutical research. A selection of important and recent patents on biomarkers is also included in the journal. The journal is essential reading for all researchers involved in biomarker research and discovery. The journal also covers recent research (where patents have been registered) in fast emerging patent biomarker applications; discovery and validation are covered for drug discovery, clinical development and molecular diagnostics.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more